Shopping Cart 0
Cart Subtotal
USD 0

Anika Therapeutics Inc (ANIK) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Anika Therapeutics Inc (ANIK)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products include viscosupplementation and regenerative orthopedics products, advanced wound care devices, anti-adhesion gels, viscoelastic ophthalmic products, dental bone grafting adjuncts and joint dysfunction management fluids for horses. Its products are made from hyaluronic acid (HA) based on two technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA. Anika has research and manufacturing facilities in Bedford, Massachusetts. The company offers its products through distributors in the Americas, Europe, the Middle East, and Asia. Anika is headquartered in Massachusetts, the US.

Anika Therapeutics Inc Key Recent Developments

Sep 05,2018: Anika appoints Dr. Cheryl Blanchard to its Board of Directors

Jul 25,2018: Anika reports second quarter 2018 financial results

May 02,2018: Anika Reports First Quarter 2018 Financial Results

Mar 05,2018: Anika Therapeutics Names Joseph Darling As CEO And Director

Feb 21,2018: Anika Announces Fourth Quarter and Full Year 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Anika Therapeutics Inc-Key Facts 6

Anika Therapeutics Inc-Key Employees 7

Anika Therapeutics Inc-Key Employee Biographies 8

Anika Therapeutics Inc-Major Products and Services 9

Anika Therapeutics Inc-History 11

Anika Therapeutics Inc-Company Statement 14

Anika Therapeutics Inc-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2-Company Analysis 16

Company Overview 16

Anika Therapeutics Inc-Business Description 17

Business Segment: Dermal 17

Overview 17

Performance 17

Business Segment: Orthobiologics 17

Overview 17

Performance 17

Business Segment: Other 17

Overview 17

Business Segment: Others 18

Performance 18

Business Segment: Surgical 18

Overview 18

Performance 18

Geographical Segment: Europe 18

Target Markets 18

Performance 18

Geographical Segment: Other 18

Target Markets 18

Performance 18

Geographical Segment: US 19

Performance 19

R&D Overview 19

Anika Therapeutics Inc-Corporate Strategy 20

Anika Therapeutics Inc-SWOT Analysis 21

SWOT Analysis-Overview 21

Anika Therapeutics Inc-Strengths 21

Anika Therapeutics Inc-Weaknesses 22

Anika Therapeutics Inc-Opportunities 23

Anika Therapeutics Inc-Threats 24

Anika Therapeutics Inc-Key Competitors 25

Section 3-Company Financial Ratios 26

Financial Ratios-Capital Market Ratios 26

Financial Ratios-Annual Ratios 27

Performance Chart 30

Financial Performance 30

Financial Ratios-Interim Ratios 31

Financial Ratios-Ratio Charts 32

Section 4-Company's Lifesciences Financial Deals and Alliances 33

Anika Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 33

Anika Therapeutics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 34

Anika Therapeutics Inc, Recent Deals Summary 35

Section 5-Company's Recent Developments 36

Sep 05, 2018: Anika appoints Dr. Cheryl Blanchard to its Board of Directors 36

Jul 25, 2018: Anika reports second quarter 2018 financial results 37

May 02, 2018: Anika Reports First Quarter 2018 Financial Results 38

Mar 05, 2018: Anika Therapeutics Names Joseph Darling As CEO And Director 40

Feb 21, 2018: Anika Announces Fourth Quarter and Full Year 2017 Financial Results 41

Oct 25, 2017: Anika Reports Third Quarter 2017 Financial Results 42

Oct 23, 2017: Anika Announces the Forthcoming Appointment of Thomas M. Finnerty as Chief Human Resources Officer 43

Aug 28, 2017: Anika Announces Appointment of Steven Chartier as Vice President of Regulatory and Clinical Affairs 44

Jul 27, 2017: Anika Announces Appointment of Joseph Darling as President 45

Jul 26, 2017: Anika Reports Strong Second Quarter 2017 Financial Results 46

Section 6-Appendix 47

Methodology 47

Ratio Definitions 47

About GlobalData 51

Contact Us 51

Disclaimer 51


List Of Figure

List of Figures

Anika Therapeutics Inc, Performance Chart (2013-2017) 30

Anika Therapeutics Inc, Ratio Charts 32

Anika Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 33

Anika Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 34


List Of Table

List of Tables

Anika Therapeutics Inc, Key Facts 6

Anika Therapeutics Inc, Key Employees 7

Anika Therapeutics Inc, Key Employee Biographies 8

Anika Therapeutics Inc, Major Products and Services 9

Anika Therapeutics Inc, History 11

Anika Therapeutics Inc, Subsidiaries 15

Anika Therapeutics Inc, Key Competitors 25

Anika Therapeutics Inc, Ratios based on current share price 26

Anika Therapeutics Inc, Annual Ratios 27

Anika Therapeutics Inc, Annual Ratios (Cont...1) 28

Anika Therapeutics Inc, Annual Ratios (Cont...2) 29

Anika Therapeutics Inc, Interim Ratios 31

Anika Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 33

Anika Therapeutics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 34

Anika Therapeutics Inc, Recent Deals Summary 35

Currency Codes 47

Capital Market Ratios 47

Equity Ratios 48

Profitability Ratios 48

Cost Ratios 49

Liquidity Ratios 49

Leverage Ratios 50

Efficiency Ratios 50

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Anika Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Vertical Spine, LLC

Repligen Corp

MiMedx Group Inc

Lattice Biologics Ltd

Citagenix Inc

Aziyo Biologics Inc